Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. (Sinopharm Rongsheng for short), a wholly-owned subsidiary of the company, received the “Drug Supplement Application Approval Notice” for calcium gluconate injections approved and issued by the State Drug Administration to approve the consistent evaluation of the quality and efficacy of generic drugs.

Zhitongcaijing · 11/26 08:49
Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. (Sinopharm Rongsheng for short), a wholly-owned subsidiary of the company, received the “Drug Supplement Application Approval Notice” for calcium gluconate injections approved and issued by the State Drug Administration to approve the consistent evaluation of the quality and efficacy of generic drugs.